Researchers analyzed 153 participants aged 18-62 years (mean age, 36 years) diagnosed with BED and enrolled in the US Binge Eating Treatment and Recovery program between 2020 and 2023. Participants ...

TITUSVILLE, N.J., Nov. 6, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved CAPLYTA ® (lumateperone) as an adjunctive therapy ...

Consuming a ketogenic diet along with medication and/or psychotherapy was associated with a nearly 70% decrease in symptoms of major depressive disorder (MDD), a small pilot study showed. After 10-12 ...

An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...

Adolescent major depressive disorder represents a personal and public health challenge. Conventional drug treatments don’t ...

According to the World Health Organization (WHO), about 332 million people around the world live with depression. Milaneschi is the co-lead author of a new study recently presented at the 2025 ECNP ...

This trip might just be worth taking. New research suggests that microdosing a popular psychedelic may provide relief for people struggling with major depressive disorder. That’s noteworthy, since ...

Depressive symptoms are common in people with asthma, but increasing evidence suggests they may be driven by biological processes that differ from those seen in major depressive disorder.

Objective To synthesise meta-analytic outcomes from randomised controlled trials examining exercise effects on depression and anxiety across all population groups, including children and adults with ...